Caramanos Z - Search Results

1

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, Pelletier D, Arnason BGW, Antel JP, Arnold DL. Narayanan S, et al. Among authors: caramanos z. J Neurol. 2001 Nov;248(11):979-86. doi: 10.1007/s004150170052. J Neurol. 2001. PMID: 11757963 Clinical Trial.

2

Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL. Santos AC, et al. Among authors: caramanos z. J Neurol. 2002 Jun;249(6):662-8. doi: 10.1007/s00415-002-0686-4. J Neurol. 2002. PMID: 12111296

3

Evidence for use of glatiramer acetate in multiple sclerosis.

Caramanos Z, Arnold DL. Caramanos Z, et al. Lancet Neurol. 2005 Feb;4(2):74-5; discussion 76-7. doi: 10.1016/S1474-4422(05)00974-9. Lancet Neurol. 2005. PMID: 15664538 No abstract available.

4

1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review.

Caramanos Z, Narayanan S, Arnold DL. Caramanos Z, et al. Brain. 2005 Nov;128(Pt 11):2483-506. doi: 10.1093/brain/awh640. Epub 2005 Oct 17. Brain. 2005. PMID: 16230321 Review.

5

Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.

Caramanos Z, Francis SJ, Narayanan S, Lapierre Y, Arnold DL. Caramanos Z, et al. Arch Neurol. 2012 Jan;69(1):89-95. doi: 10.1001/archneurol.2011.765. Arch Neurol. 2012. PMID: 22232348

6

Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients.

Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Cendes F, et al. Among authors: caramanos z. Ann Neurol. 1997 Nov;42(5):737-46. doi: 10.1002/ana.410420510. Ann Neurol. 1997. PMID: 9392573

7

In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.

De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL. De Stefano N, et al. Among authors: caramanos z. Ann Neurol. 1998 Aug;44(2):273-8. doi: 10.1002/ana.410440222. Ann Neurol. 1998. PMID: 9708554

8

Neuronal dysfunction in children with newly diagnosed temporal lobe epilepsy.

Miller SP, Li LM, Cendes F, Caramanos Z, Rosenblatt B, Shevell MI, Andermann F, Arnold DL. Miller SP, et al. Among authors: caramanos z. Pediatr Neurol. 2000 Apr;22(4):281-6. doi: 10.1016/s0887-8994(99)00159-9. Pediatr Neurol. 2000. PMID: 10788744

9

Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.

Kalra S, Cashman NR, Caramanos Z, Genge A, Arnold DL. Kalra S, et al. Among authors: caramanos z. AJNR Am J Neuroradiol. 2003 Mar;24(3):476-80. AJNR Am J Neuroradiol. 2003. PMID: 12637300 Free PMC article.

10

(1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.

Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL. Caramanos Z, et al. J Neurol Sci. 2009 Jul 15;282(1-2):72-9. doi: 10.1016/j.jns.2009.01.015. Epub 2009 Feb 20. J Neurol Sci. 2009. PMID: 19232641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters